Detailed information for compound 1890653

Basic information

Technical information
  • TDR Targets ID: 1890653
  • Name: N'-[(3,4-dimethoxyphenyl)methylideneamino]-N- phenylbutanediamide
  • MW: 355.388 | Formula: C19H21N3O4
  • H donors: 2 H acceptors: 2 LogP: 1.86 Rotable bonds: 10
    Rule of 5 violations (Lipinski): 1
  • SMILES: COc1cc(/C=N/NC(=O)CCC(=O)Nc2ccccc2)ccc1OC
  • InChi: 1S/C19H21N3O4/c1-25-16-9-8-14(12-17(16)26-2)13-20-22-19(24)11-10-18(23)21-15-6-4-3-5-7-15/h3-9,12-13H,10-11H2,1-2H3,(H,21,23)(H,22,24)/b20-13+
  • InChiKey: JEIUAISUPHEZDV-DEDYPNTBSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

  • N'-[(3,4-dimethoxyphenyl)methyleneamino]-N-phenyl-butanediamide
  • N'-[(3,4-dimethoxyphenyl)methyleneamino]-N-phenylbutanediamide
  • N'-[(3,4-dimethoxybenzylidene)amino]-N-phenyl-succinamide
  • N'-[(3,4-dimethoxyphenyl)methylideneamino]-N-phenyl-butanediamide
  • 4-[(2E)-2-(3,4-dimethoxybenzylidene)hydrazino]-4-oxo-N-phenylbutanamide
  • MLS000584338
  • SMR000203501

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens glucagon-like peptide 1 receptor Starlite/ChEMBL No references
Escherichia coli penicillin-binding protein Starlite/ChEMBL No references

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Mycobacterium tuberculosis Possible penicillin-binding protein Get druggable targets OG5_149948 All targets in OG5_149948
By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Loa Loa (eye worm) pigment dispersing factor receptor c glucagon-like peptide 1 receptor 463 aa 388 aa 25.8 %
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Plasmodium falciparum biotin carboxylase subunit of acetyl CoA carboxylase, putative 0.0279 0.6669 0.5
Trypanosoma brucei 3-methylcrotonyl-CoA carboxylase alpha subunit, putative 0.0147 0.2536 0.1741
Mycobacterium ulcerans acetyl-/propionyl-coenzyme a carboxylase alpha chain AccA1 0.0147 0.2536 0.5
Plasmodium vivax biotin carboxylase subunit of acetyl CoA carboxylase, putative 0.0279 0.6669 0.5
Mycobacterium ulcerans pyruvate carboxylase 0.0147 0.2536 0.5
Giardia lamblia Acetyl-CoA carboxylase/pyruvate carboxylase fusion protein, putative 0.0066 0 0.5
Echinococcus multilocularis acetyl coenzyme A carboxylase 1 0.0385 1 1
Trypanosoma cruzi acetyl-CoA carboxylase 0.0239 0.5408 1
Toxoplasma gondii acetyl-CoA carboxylase ACC1 0.0385 1 1
Trypanosoma brucei acetyl-CoA carboxylase 0.0385 1 1
Wolbachia endosymbiont of Brugia malayi Acetyl/propionyl-CoA carboxylase, alpha subunit 0.0147 0.2536 0.5
Mycobacterium tuberculosis Possible penicillin-binding protein 0.0278 0.6633 1
Schistosoma mansoni acetyl-CoA carboxylase 0.0385 1 1
Toxoplasma gondii acetyl-coA carboxylase ACC2 0.0385 1 1
Entamoeba histolytica acetyl-coA carboxylase, putative 0.0066 0 0.5
Mycobacterium ulcerans bifunctional protein acetyl-/propionyl-coenzyme a carboxylase (alpha chain) AccA3 0.0147 0.2536 0.5
Leishmania major acetyl-CoA carboxylase, putative 0.0385 1 1
Brugia malayi Carboxyl transferase domain containing protein 0.0372 0.9578 0.5
Loa Loa (eye worm) carboxyl transferase domain-containing protein 0.0372 0.9578 0.5
Chlamydia trachomatis biotin carboxylase 0.0133 0.2114 0.5
Trypanosoma brucei 3-methylcrotonyl-CoA carboxylase alpha subunit, putative 0.0147 0.2536 0.1741
Mycobacterium leprae Probable bifunctional protein acetyl-/propionyl-coenzyme A carboxylase, alpha chain AccA3 (BccP) 0.0147 0.2536 0.5
Mycobacterium ulcerans acetyl-/propionyl-coenzyme a carboxylase alpha chain, AccA2 0.0147 0.2536 0.5

Activities

Activity type Activity value Assay description Source Reference
Potency (functional) = 5.0119 um PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))] ChEMBL. No reference
Potency (functional) 12.5893 uM PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) 39.8107 uM PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] ChEMBL. No reference
Potency (functional) = 50.1187 um PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of DNA Polymerase Beta. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) 50.1187 uM PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.